Doximity, Inc. (DOCS) · Aug 6, 2026 · Company update

Revenue and EBITDA beat guidance decisively, despite sharp margin compression

Revenue and EBITDA beat guidance decisively, despite sharp margin compression

The quarter cleared the company’s own bar by a wide margin. Doximity guided to $151–152 million of revenue and $68.5–69.5 million of adjusted EBITDA; it delivered $156.6 million and $74.8 million, respectively. That is roughly $4.6–5.6 million above the revenue range and $5.3–6.3 million above the EBITDA range.

MetricQ1 FY27Q1 FY26Change / expectation
Revenue$156.6M$145.9M+7.3%; above $151–152M guide (Income Statement)
GAAP net income$24.3M$53.3M-54.4%; 15.5% margin vs. 36.5% (Income Statement)
Non-GAAP net income$55.0M$71.9M-23.5%; 35.1% margin vs. 49.2% (Non-GAAP reconciliation)
Diluted non-GAAP EPS$0.29$0.36Below the published consensus of roughly $0.30 (Non-GAAP reconciliation)
Adjusted EBITDA$74.8M$79.8M-6.3%; 47.7% margin vs. 54.7% (Adjusted EBITDA reconciliation)
Operating cash flow$42.0M$62.1M-32.4% (Cash Flow statement)
Free cash flow$39.6M$60.1M-34.1% (Free Cash Flow reconciliation)

The operating result was better than feared, but the earnings quality was less clean. Revenue accelerated to 7.3% year over year, while workflow-active prescribers grew more than 30% and AI Search queries rose more than 25% sequentially (Company commentary). However, GAAP operating expenses jumped 31%, including a 68% increase in research and development and a 24% increase in sales and marketing (Income Statement). Stock-based compensation also rose to $36.8 million from $21.9 million (Stock-Based Compensation table), helping explain why adjusted EBITDA declined despite higher revenue.

The main deterioration is margin, not demand. GAAP gross margin fell to 84.9% from 89.2%, and adjusted EBITDA margin dropped to 47.7% from 54.7% (Non-GAAP reconciliation). Free cash flow also fell by one-third, partly reflecting a $33.3 million increase in accounts receivable (Cash Flow statement). Those trends temper the headline beat: Doximity is growing and monetizing engagement, but it is spending substantially more to do so.

The net read is positive because the revenue and EBITDA outperformance outweigh the profitability giveback. The filing shows a meaningful beat versus the standing quarterly guide, while diluted non-GAAP EPS was approximately in line to slightly below the published consensus. The $91.6 million share repurchase reduced diluted weighted-average shares to 191.2 million from 201.2 million, and cash plus marketable securities remained roughly $688 million at quarter-end (Balance Sheet; Cash Flow statement). The key change is therefore stronger near-term execution than expected, offset by evidence that AI and workflow expansion are currently carrying a higher cost and cash-flow burden.

Original filing on SEC EDGAR

More Doximity, Inc. news

Revenue and EBITDA beat guidance decisively, despite sharp margin compression | DOCS Stock News
AllSight

Breaking down Wall Street's
information edge.

A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.

—
8-K events this week
—
filings analyzed in total
live · updated 30s ago
Live events · whole market · · --:--:-- ET
AllSight read
Straight from the 8-K
Verbatim from the filing AllSight decoded — highlighted above. Open on SEC EDGAR ↗
Limited-time offerFree 14-day Pro trial
AllSight

Sign in to AllSight

  • Follow any company — we email you the moment it files, free!
  • Your watchlist saved to your account, on every device — free!

by Signing in NOW, claim your FREE 14-day Pro trial!

No password. We email you a 6-digit code. By continuing you agree to our Terms & Privacy.
AllSight · Live plain-English 8-K decodes across the whole US market · Not investment advice.